C18-C21 C18 C19 C20 C21
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Individuals aged 40-49 at the planned start of their studies (Main study 45-49 years, explorative cohort 40,41). - Contactable via email address (with a user account at BARMER).
Exclusion criteria
Exclusion criteria: - Established contact restriction - Previous colonoscopy (EBM 13421, OPS 1-650) - Previous invitation through the program (applies to exploratory cohort aged 40–41) - Stool test use in the past 12 months (EBM 32457) - Previous diagnosis of: Crohn's disease (ICD-10: K50) Ulcerative colitis (ICD-10: K51) Colorectal Cancer (ICD-10: C18–C21)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of insured persons aged 45-49 with polypectomy or colorectal cancer diagnosis within 12 months of receiving the initial invitation. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Proportion of insured persons aged 45-49 who used a FIT within 12 months of the initial invitation. • Rate of diagnostic colonoscopy (EBM 13421, OPS1-650) within 12 months of invitation. • Proportion of insured persons with a positive FIT within 8 weeks of invitation (aggregated data). • Proportion of insured persons who underwent polypectomy within 12 months of receiving the initial invitation. • Proportion of insured persons diagnosed with colorectal cancer within 12 months of receiving the initial invitation. | — |
Countries
Germany
Contacts
Deutsches Krebsforschungszentrum